To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED)

NCT00271817 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1220

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Comparator: ezetimibe/simvastatin + niacin (ER)
DRUG: Comparator: Placebo to ezetimibe/simvastatin
DRUG: Comparator: niacin (ER) tablet
DRUG: Comparator: ezetimibe (+) simvastatin
DRUG: Comparator: Placebo to Niacin (ER)
DRUG: Comparator: ezetimibe/simvastatin and niacin (ER)
DRUG: Comparator: ezetimibe and simvastatin
DRUG: Comparator: Placebo to niacin (ER)

Sponsor

Organon and Co